FLT3 and acute myeloid leukemia: One of the most common mutations in AML occurs in the open reading frame of FMS-like tyrosine kinase 3 (FLT3), which is the receptor for FLT3-ligand, a cytokine with pivotal function in dendritic cell (DC) differentiation and in stem cell renewal [2, 3].